Systemic Sclerosis (Scleroderma): Clinical Trials

1 trial for Systemic Sclerosis (Scleroderma), newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Terminated 1
Phase 21Terminated 1

Follow Systemic Sclerosis (Scleroderma): new trials by email Literature Review of Systemic Sclerosis (Scleroderma) trials Research Report on Systemic Sclerosis (Scleroderma)

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Treatment of Early Systemic Sclerosis by Bosentan
bosentan - Systemic Sclerosis (Scleroderma)
Phase 1 / Phase 2TerminatedRikshospitalet University Hospital302005-01-012009-06-12

Narrower conditions

Fibrosis (1)  ·  Scleroderma, Diffuse (1)  ·  Scleroderma, Systemic (1)

Broader conditions

Connective Tissue Diseases (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Skin Diseases (1)  ·  Skin and Connective Tissue Diseases (1)

Interventions

Bosentan (1)

Sponsors

Rikshospitalet University Hospital (1)

Countries

Norway (1)

Top investigators

Jan T Gran, Professor (1)